Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.480
-0.010 (-0.29%)
At close: Jan 13, 2026, 4:00 PM EST
3.420
-0.060 (-1.72%)
Pre-market: Jan 14, 2026, 8:31 AM EST
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $225.33 million as of January 14, 2026. Its market cap has decreased by -1.80% in one year.
Market Cap
225.33M
Enterprise Value
-14.91M
1-Year Change
-1.80%
Ranking
Category
Stock Price
$3.48
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $225.33M, a decrease of -61.64%. That is a compound annual growth rate of -15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 225.98M | 158.52% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.38B |
| Johnson & Johnson | 504.60B |
| AbbVie | 388.47B |
| UnitedHealth Group | 307.51B |
| AstraZeneca | 295.57B |
| Novartis AG | 274.30B |
| Merck & Co. | 270.66B |
| Novo Nordisk | 263.26B |